Soleno Therapeutics Inc’s filing revealed that its 10% Owner Vivo Opportunity, LLC unloaded Company’s shares for reported $15.85 million on Apr 30 ’24. In the deal valued at $45.13 per share,351,242 shares were sold. As a result of this transaction, Vivo Opportunity, LLC now holds 7,316,851 shares worth roughly $330.14 million.
Then, Vivo Opportunity, LLC sold 750,000 shares, generating $35,850,000 in total proceeds. Upon selling the shares at $47.80, the 10% Owner now owns 7,668,093 shares.
Before that, Anish Bhatnagar sold 18,980 shares. Soleno Therapeutics Inc shares valued at $784,645 were divested by the CHIEF EXECUTIVE OFFICER at a price of $41.34 per share. As a result of the transaction, Anish Bhatnagar now holds 152,790 shares, worth roughly $6.89 million.
Piper Sandler initiated its Soleno Therapeutics Inc [SLNO] rating to an Overweight in a research note published on February 05, 2024; the price target was $93. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. Guggenheim started covering the stock on September 29, 2020. It rated SLNO as “a Buy”.
Price Performance Review of SLNO
On Friday, Soleno Therapeutics Inc [NASDAQ:SLNO] saw its stock fall -8.35% to $45.12. Over the last five days, the stock has gained 19.08%. Soleno Therapeutics Inc shares have risen nearly 12.10% since the year began. Nevertheless, the stocks have risen 1160.34% over the past one year. While a 52-week high of $53.82 was reached on 02/28/24, a 52-week low of $3.48 was recorded on 01/04/24. SMA at 50 days reached $43.02, while 200 days put it at $29.46. A total of 1.6 million shares were traded, compared to the trading of 0.32 million shares in the previous session.
Levels Of Support And Resistance For SLNO Stock
The 24-hour chart illustrates a support level at 43.90, which if violated will result in even more drops to 42.69. On the upside, there is a resistance level at 47.41. A further resistance level may holdings at 49.71. The Relative Strength Index (RSI) on the 14-day chart is 56.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 6.25, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 50.49%. Stochastics %K at 62.17% indicates the stock is a holding.
The most recent change occurred on January 10, 2020 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
